Related content

Expression of matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinase (TIMP) in cerebral cavernous malformations: immunohistochemical analysis of MMP-2, -9 and TIMP-2

By Fujimura M.   Watanabe M.   Shimizu H.   Tominaga T.  

Acta Neurochirurgica, Vol. 149, Iss. 2, 2007-02 ,pp. : 179-183

Springer Publishing Company

Access to resources Recommend Favorite

Gelatinase B/matrix metalloproteinase-9 cleaves interferon- and is a target for immunotherapy

By Nelissen I.   Martens E.   van den Steen P.E.   Proost P.   Ronsse I.   Opdenakker G.  

Brain, Vol. 126, Iss. 6, 2003-06 ,pp. : 1371-1381

Oxford University Press

Access to resources Recommend Favorite

Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis

By Leppert D   Ford J   Stabler G   Grygar C   Lienert C   Huber S   Miller KM   Hauser SL   Kappos L  

Brain, Vol. 121, Iss. 12, 1998-12 ,pp. : 2327-2334

Oxford University Press

Access to resources Recommend Favorite

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

By Hirst C.   Pace A.   Pickersgill T.   Jones R.   McLean B.   Zajicek J.   Scolding N.   Robertson N.  

Journal of Neurology, Vol. 255, Iss. 2, 2008-02 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Elevated levels of matrix metalloproteinases-9 and -1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy

By Lorenzl S.   Albers D.S.   Chirichigno J.W.   Augood S.J.   Beal M.F.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 39-45

Elsevier

Access to resources Recommend Favorite